David Evans
Partner
Works at Sofinnova
Investor profile | Builders Republic
About
Partner at Sofinnova, David Evans invests in pre-seed, seed, Series A, Series B, and growth with check sizes ranging from €1M to €60M, focusing on health and life sciences, agri-food, and climate. He is a Partner in the Crossover Strategy, where he joined in June 2026 with over 20 years of experience. Previously, he was Investment Director at the Roche Venture Fund, after roles at Roche, BMS, and Eli Lilly. Education: medical degree (Sydney) and PhD in clinical epidemiology.
Profile
- Role
- Partner
- Fund
- Sofinnova